Ipamorelin and sermorelin turn up constantly in online anti-aging and bodybuilding forums, marketed as a gentler, more "natural" route to raising growth hormone than injecting synthetic HGH directly. The pitch sounds reasonable, but the question patients actually need answered is simpler: are these two peptides actually legal in the UK? This guide explains what growth hormone secretagogues are, what the evidence for ipamorelin and sermorelin actually shows, exactly where UK medicines law leaves them, and the real risks of using an unlicensed product bought online.
What growth-hormone secretagogues are
Growth hormone secretagogues (GHS) are a class of compounds that prompt the pituitary gland to release more of its own growth hormone, rather than supplying growth hormone (somatropin) directly. That distinction is the entire basis of how these products are marketed, as a way of boosting the body's natural GH pulses instead of injecting a synthetic hormone.
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), built from the first 29 amino acids of the natural hormone that signals the pituitary to release GH. It was previously sold in the United States under the brand name Geref for diagnostic testing of pituitary GH reserve, but that product was discontinued years ago and no UK-licensed equivalent exists.
Ipamorelin works differently. It is a synthetic pentapeptide that acts on the ghrelin receptor, a separate pathway that also triggers GH release. Early research suggested it may act more selectively on that receptor than older ghrelin-receptor agonists, with less effect on cortisol and prolactin, but this comes from small early-phase and preclinical studies, not the kind of large clinical trial programme that supports a licensed medicine. Sellers sometimes combine the two, on the theory that a GHRH analogue and a ghrelin-receptor agonist target the GH axis from two directions at once, a pairing our guide to peptide stacking looks at in more detail.
Claimed benefits vs evidence
Online sellers and some private anti-aging clinics market ipamorelin and sermorelin for increased lean muscle, reduced body fat, better sleep, faster recovery from exercise, and general vitality. These are wellness claims aimed at healthy adults who do not have a diagnosed growth hormone problem, and that is precisely where the evidence gap sits.
Sermorelin's clinical history is mostly diagnostic: it was studied to help confirm whether a patient's pituitary could still respond to GHRH, and in some smaller trials, decades ago, in children with confirmed growth hormone deficiency. That is a narrow, specific use case, not evidence that healthy adults will see the muscle, fat-loss or anti-aging results used to sell it today. Ipamorelin's evidence base is thinner still, largely limited to studies looking at whether it raises GH levels in the short term, rather than long-term studies measuring the outcomes actually advertised, such as body composition or recovery.
Genuine adult growth hormone deficiency is a recognised, if uncommon, medical condition, and it is managed very differently from how these peptides are sold online: through specialist endocrinology assessment, confirmed diagnostic testing, and closely monitored treatment with a licensed medicine. Self-directed use of an unlicensed peptide bought on the strength of a forum thread is not a substitute for that pathway, and there is no robust trial evidence that it delivers the wellness benefits claimed for it in a healthy adult.
UK legal and licensing position
Neither ipamorelin nor sermorelin holds a UK marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for any indication. Sermorelin's old US diagnostic licence was withdrawn and never had a UK counterpart, and ipamorelin has never been through the MHRA approval process at all. As with peptides generally, a product intended for human therapeutic use normally needs that authorisation before it can lawfully be sold or supplied for that purpose, and neither of these peptides has it.
Most sellers get around this by labelling their products "research chemicals, not for human consumption." That wording is a positioning statement, not a safety standard or a legal green light. Our guide to whether peptides are legal in the UK sets out why regulators look at how a product is actually marketed and used, not just the disclaimer printed on the label, when deciding whether it is being supplied as a medicine.
It is also worth being precise about what kind of law applies. Growth hormone secretagogues are not listed by name as controlled drugs under the Misuse of Drugs Act 1971, unlike anabolic steroids and human growth hormone (somatropin) itself, which are Class C controlled substances. That does not make ipamorelin or sermorelin legal to sell, it simply means an unlicensed sale sits under medicines regulation rather than drug-trafficking law. Anyone competing in regulated sport should also be aware that growth hormone secretagogues, ipamorelin and sermorelin included, are prohibited at all times under the World Anti-Doping Agency's Prohibited List, regardless of their domestic legal status. For a sense of how fast this regulatory picture is moving internationally, see our piece on the FDA's 2026 peptide changes.
Risks of unregulated products
Products sold as research chemicals are not manufactured to the good manufacturing practice standards that licensed medicines require. There is no independent guarantee that a vial contains what the label says, at the concentration stated, or that it was manufactured and stored in a way that keeps it sterile and stable. Our guide to reconstituting peptides at home covers the practical hazards of mixing and injecting an unverified product outside a clinical setting, including the infection risk that comes with home reconstitution.
There are physiological considerations too. Stimulating the GH axis is not a neutral intervention: in a clinical setting it is accompanied by monitoring of markers such as IGF-1 and blood glucose, precisely because raised GH activity can plausibly affect fluid balance, insulin sensitivity and joint comfort. Nobody is monitoring for those effects when a peptide is bought online and self-administered, and there is no formal safety data on ipamorelin or sermorelin at the doses and durations people typically use for wellness purposes.
Finally, there is no prescriber assessing whether either peptide is appropriate alongside your other medicines or existing health conditions, and no reliable record of what was actually taken if something goes wrong. Buying a product that has not been through UK medicines regulation also carries a straightforward legal risk of its own, separate from any health risk.
When to speak to a clinician
If you are experiencing symptoms that concern you, such as unusual fatigue, loss of muscle mass, or poor recovery, the safe next step is assessment by your GP or a UK-registered clinician, not a peptide bought online on the strength of a forum recommendation. A clinician can arrange the right tests, including IGF-1 levels and, where indicated, formal GH stimulation testing, and refer you on to specialist endocrinology if a genuine deficiency is suspected.
Confirmed adult growth hormone deficiency is treated with licensed somatropin under specialist supervision, with regular monitoring built into the treatment plan from the start. That pathway looks nothing like buying an unlicensed peptide online, and it exists precisely to make sure any growth hormone treatment is both appropriate for you and properly supervised. If you have questions about your general health, an injectable treatment you have seen marketed, or what a safe, regulated route might look like for you, a free consultation with a UK-registered clinician is a better starting point than a research-chemical vial with no prescriber behind it.